The P&G-Merck KGaA Consumer Health Business Merger
| Case Code: BSTR618
Case Length: 14 Pages
Pub Date: 2020
Teaching Note: Available
| Price: Rs.400
Organization: Procter & Gamble Company
Countries: United States
Themes: M&A, Divestment
Abstract Case Intro 1 Case Intro 2 Excerpts
The case study ‘The P&G-Merck KGaA Consumer Health Business Merger’ discusses the M&A deal between the Germany-based global pharmaceutical company Merck KGaA and the US-based, multinational FMCG company P&G. In this deal, P&G acquired a 100% stake in the consumer health business of Merck KGaA for US$4.2 billion. The case helps the students understand the various aspects of an M&A deal. It explores the rationale behind the merger deal, from both P&G’s and Merck KGaA’s perspective. It discusses the various developments that took place before and after the merger was announced. The case provides sufficient scope to debate the various possible synergies and various challenges related to this deal. The case ends with a debate on whether the merger would be successful or not.
The case is structured to achieve the following teaching objectives:
- To understand the various challenges related to any cross-border M&A and explore strategies to overcome those challenges.
- Understand how Design Thinking helps companies in creating a better customer experience.
- Analyze the various motives behind acquisitions.
- Understand acquisition as a growth strategy.
A Note On Procter & Gamble
Product Portfolio Restructuring at P&G
A Board Seat for Nelson Peltz
A Note on Merck Kgaa
Merck puts consumer health business on the Block
Bidding Process Starts for Merck’s Chb
Cross-border M&A; Expansion Strategy, Acquisition; Growth strategy; Business Strategy Analysis; Integration challenges; Consumer Health Business; Radical changes; Bidding Process, OTC Segment; Procter & Gamble Company; Merck KGaA
Buy this case study (Please select any one of the payment options)
||Price: Rs.400||PayPal (9 USD)